Centre Hospitalier Valence

The Centre Hospitalier Valence in Medical oncology is actively studying a wide range of neoplasms and blood cancers, including multiple myeloma, follicular lymphoma, myelodysplastic syndromes, colon cancer, and advanced biliary cancer. These trials are designed to improve treatment effectiveness, refine maintenance strategies, and test new combinations for patients with solid tumors and hematologic disorders.

• Testing new treatment combinations for myelodysplastic syndromes and other blood disorders
• Evaluating better approaches for multiple myeloma and follicular lymphoma
• Assessing therapies for colon cancer, biliary tract cancer, and other advanced cancers

Much of the research focuses on improving survival outcomes, delaying relapse, and finding more effective options for patients with difficult-to-treat cancers.

Research at this site also covers digestive system diseases, especially Crohn’s disease and ulcerative colitis. The studies aim to compare biologic and targeted therapies, improve remission rates, and better control symptoms and inflammation in people whose disease is not fully managed with standard treatment.

• Comparing treatment strategies for Crohn’s disease after loss of response to therapy
• Studying approaches to maintain remission in ulcerative colitis
• Evaluating whether newer medicines can improve clinical remission and reduce inflammatory activity

These trials are focused on helping patients achieve more stable disease control and a better quality of life through more personalized care.

The site is conducting trials in skin and connective tissue diseases and immune system diseases, including moderate-to-severe plaque psoriasis and prurigo nodularis. The research is aimed at testing new therapies and adjusting treatment approaches to improve symptom control and long-term safety.

• Assessing new options for psoriasis in patients with higher body weight or difficult-to-treat disease
• Evaluating long-term safety and effectiveness in prurigo nodularis
• Exploring improved control of chronic inflammatory skin disease

These studies reflect a strong interest in therapies that may offer better relief for persistent inflammatory skin disorders.

Clinical trial activity at Centre Hospitalier Valence includes several cancers of the nervous system, digestive tract, and neoplasms more broadly, with a strong emphasis on advanced solid tumors such as non-small cell lung cancer, melanoma, head and neck squamous cell carcinoma, and ovarian cancer. The purpose of these studies is to compare new immunotherapy, targeted therapy, and chemotherapy-based strategies to improve outcomes after surgery or in advanced disease.

• Testing new immunotherapy combinations in melanoma and head and neck cancer
• Evaluating targeted treatment for MET exon 14 mutated non-small cell lung cancer
• Studying treatment strategies for ovarian cancer and other advanced solid tumors

Overall, this research aims to strengthen cancer control by finding more effective and better-tolerated treatment options.

The trial portfolio also includes work in bacterial infections and mycoses, nervous system diseases, and broader supportive care questions. At the site, studies are exploring better management of septic arthritis, intracerebral haemorrhage, and infection-related complications in patients receiving cancer treatment.

• Improving treatment for septic arthritis and related inflammatory joint disease
• Evaluating ways to support patients with intracerebral haemorrhage
• Testing infection management strategies in haematology and oncology care

These studies show that the site’s research extends beyond cancer treatment to include practical questions that may improve patient safety and day-to-day care.